|
Chen, Chu |
Fred Hutchinson Cancer Research Center |
Infrastructure Support and Pilot Tissue Collection for the CARET Biorepository |
Chemopreventive Agent Development |
PAR-15-104: Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts |
|
Cheng, Susan |
Cedars-Sinai Medical Center |
Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2 |
Cancer Biomarkers, COVID Serology |
RFA-CA-20-038: Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence |
|
Chibwesha, Carla J |
Univ Of North Carolina Chapel Hill |
Acceptability and feasibility of combination treatment for cervical precancer among South Africa women living with HIV |
Breast and Gynecologic Cancer |
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
|
Chilkoti, Ashutosh |
Duke University |
Smartphone Enabled Point-of-Care Detection of Serum Markers of Liver Cancer |
Cancer Biomarkers |
RFA-CA-15-024: Cancer Detection, Diagnosis, and Treatment Technologies for Global Health (UG3/UH3) |
|
Chinnaiyan, Arul M |
University Of Michigan At Ann Arbor |
Discovery and qualification of transcriptomic biomarkers for the early detection of aggressive prostate cancer |
Cancer Biomarkers |
RFA-CA-16-009: The Early Detection Research Network: Biomarker Developmental Laboratories |
|
CHINTHALAPALLY, RAO, |
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR |
In Vivo Evaluation of a Chemopreventive Agent, Ciclesonide, in Mouse Lung Tumor Model by Inhalation |
|
|
|
CHINTHALAPALLY, RAO, |
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR |
Characterization of Potential Antigens for Immunization Against Colon Cancer and Testing Multivalent Tumor Vaccines in Min Mice |
|
|
|
Chow, H-H. Sherry |
University Of Arizona |
University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet) |
Lung and Upper Aerodigestive Cancer |
PA-18-906: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) |
|
CHOW, ERIC JESSEN |
FRED HUTCHINSON CANCER RESEARCH CENTER |
Improving treatment of cardiovascular risk factors in childhood cancer survivors |
|
PA-13-302: |
|
Chung, Fung-Lung |
Georgetown University |
gamma-OHPdG as a prognostic biomarker of HCC recurrence and its prevention |
Cancer Biomarkers |
PAR-15-307: Translational Studies on Adducts for Cancer Risk Identification and Prevention |
|
Chung, Ki Young |
Prisma Health-Upstate |
NCORP of the Carolinas (Greenville Health System NCORP) |
Community Oncology and Prevention Trials |
RFA-CA-18-016: NCI Community Oncology Research Program (NCORP) Community Sites |
|
Clapper, Margie L. |
Research Inst Of Fox Chase Can Ctr |
Targeted Chemoprevention of Flat and Polypoid Colitis-associated Dysplasias |
Chemopreventive Agent Development |
PA-13-302: Research Project Grant |
|
Clinton, Steven K |
Ohio State University |
Translating Novel Antitumor Targets of Vitamin E into New Chemopreventive Agents |
Chemopreventive Agent Development |
PA-11-260: Research Project Grant |
|
Clinton, Steven K |
Ohio State University |
Interactive Omics: Black raspberry metabolites and the oral microbiome in smokers |
Nutritional Science |
PAR-13-159: The Role of Microbial Metabolites in Cancer Prevention and Etiology |
|
Cole, Peter D |
Rbhs -Cancer Institute Of New Jersey |
Identifying children with subclinical neurocognitive decline and susceptibility to oxidative damage during the early months of therapy for ALL |
Community Oncology and Prevention Trials |
PAR-16-218: Research Answers to NCIs Pediatric Provocative Questions |
